This is in fact the case, i.e., in B-CLL, where both hERG1 and Kv1.3 overexpressions confer a survival advantage on proliferating lymphoid cancer cells (22, 34). Here, KCNA3 is linked to B-cell chronic lymphocytic leukemia.